Grant: Canada Research Chairs
University of Toronto
$100,000.00
Quantitative Cell Biology
FY 2024-25
Summary
Over decades of research, numerous negative and positive regulators of signal transduction have been identified. What remains less clear is how these negative and positive regulators converge to specify specific values and magnitudes? In 1975, Nurse and Hartwell postulated that the size of animal cells is determined by cell size checkpoints – molecular mechanisms that sense cell size to selectively promote the growth of cells that smaller than their target size. In 2018 – after a gap of almost 50 years – Dr. Kafri, a Canada Research Chair in Quantitative Cell Biology, has identified a molecular signal that is selectively activated in cells that are smaller than ‘appropriate’. Dr. Kafri’s work represents the first molecular mechanism of size sensing to have ever been reported in animal cells.
Quantitative phenotypes are not limited to cell size. Just as checkpoint mechanisms function to specify a different and specific cell size for each of the different cell types, there must also be mechanisms that specify a different and specific lifespan value for each of the different mammalian species. How is it that a mouse dies of old age after two years of life while fruit bats live to the age of 40?
Dr. Kafri is aiming to decipher the molecular mechanisms that determine the quantitative phenotypes such as cell size and lifespan. mTORC1 signaling is known to promote cellular growth, accelerate aging and cause earlier onset of age-dependent disease, including cancers. Using cutting-edge techniques such as high content screening and computational biology, Dr. Kafri will examine how positive and negative regulators of mTORC1 signaling influence the specific values associated with cell size and lifespan.
The questions addressed by Dr. Kafri have a profound impact on human health. It is not age, but rather, age-related diseases that bring about the end of life. By identifying the mTORC1-dependent mechanisms that specify cell size and lifespan, he will identify new drug targets and exploit novel therapeutic approaches for the prevention of old age-related diseases, including the prevention of cancer.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CRC-2021-00066
Name nom
Kafri, Ran
Department département
Cell Biology - Hospital for Sick Children
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2021
Award amount
100000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1060206
Field of research list names en
Intracellular signaling, signal transduction, receptor and membrane biology
Field of research list names fr
Signalisation intracellulaire, transduction des signaux, biologie des récepteurs et des membranes
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Quantitative Cell Biology
Keywords
cell size; cell cycle; growth rate; lifespan; cancer
Application summary
Over decades of research, numerous negative and positive regulators of signal transduction have been identified. What remains less clear is how these negative and positive regulators converge to specify specific values and magnitudes? In 1975, Nurse and Hartwell postulated that the size of animal cells is determined by cell size checkpoints – molecular mechanisms that sense cell size to selectively promote the growth of cells that smaller than their target size. In 2018 – after a gap of almost 50 years – Dr. Kafri, a Canada Research Chair in Quantitative Cell Biology, has identified a molecular signal that is selectively activated in cells that are smaller than ‘appropriate’. Dr. Kafri’s work represents the first molecular mechanism of size sensing to have ever been reported in animal cells.
Quantitative phenotypes are not limited to cell size. Just as checkpoint mechanisms function to specify a different and specific cell size for each of the different cell types, there must also be mechanisms that specify a different and specific lifespan value for each of the different mammalian species. How is it that a mouse dies of old age after two years of life while fruit bats live to the age of 40?
Dr. Kafri is aiming to decipher the molecular mechanisms that determine the quantitative phenotypes such as cell size and lifespan. mTORC1 signaling is known to promote cellular growth, accelerate aging and cause earlier onset of age-dependent disease, including cancers. Using cutting-edge techniques such as high content screening and computational biology, Dr. Kafri will examine how positive and negative regulators of mTORC1 signaling influence the specific values associated with cell size and lifespan.
The questions addressed by Dr. Kafri have a profound impact on human health. It is not age, but rather, age-related diseases that bring about the end of life. By identifying the mTORC1-dependent mechanisms that specify cell size and lifespan, he will identify new drug targets and exploit novel therapeutic approaches for the prevention of old age-related diseases, including the prevention of cancer.